DrugPatentWatch Database Preview

Sun Pharm Inds Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARM INDS, and when can generic versions of SUN PHARM INDS drugs launch?

SUN PHARM INDS has two hundred and thirty-two approved drugs.

There are fourteen US patents protecting SUN PHARM INDS drugs. There are four tentative approvals on SUN PHARM INDS drugs.

There are fifty-seven patent family members on SUN PHARM INDS drugs in twenty-five countries and two hundred and eighteen supplementary protection certificates in fourteen countries.

Summary for Sun Pharm Inds

International Patents:	57
US Patents:	14
Tradenames:	171
Ingredients:	160
NDAs:	232

Drugs and US Patents for Sun Pharm Inds

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sun Pharm Inds Ltd	MINOCYCLINE HYDROCHLORIDE	minocycline hydrochloride	TABLET, EXTENDED RELEASE;ORAL	091118-008	Sep 25, 2014	AB	RX	No	No
Sun Pharm Inds Ltd	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076607-003	Dec 15, 2004		DISCN	No	No
Sun Pharm Inds Ltd	ATORVASTATIN CALCIUM	atorvastatin calcium	TABLET;ORAL	076477-002	Nov 30, 2011	AB	RX	No	No
Sun Pharm Inds Ltd	SIMVASTATIN	simvastatin	TABLET;ORAL	076285-003	Dec 20, 2006		DISCN	No	No
Sun Pharm Inds Ltd	ACYCLOVIR	acyclovir	TABLET;ORAL	074980-002	Sep 30, 1998		DISCN	No	No
Sun Pharm Inds (in)	EXTENDED PHENYTOIN SODIUM	phenytoin sodium	CAPSULE;ORAL	040621-001	Dec 11, 2006	AB	RX	No	No
Sun Pharm Inds Ltd	RISPERIDONE	risperidone	TABLET, ORALLY DISINTEGRATING;ORAL	078464-005	Apr 8, 2013	AB	RX	No	No

Expired US Patents for Sun Pharm Inds

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sun Pharm Inds Inc	ULTRAVATE	halobetasol propionate	CREAM;TOPICAL	019967-001	Dec 27, 1990	4,619,921
Sun Pharm Inds Inc	ULTRAVATE	halobetasol propionate	OINTMENT;TOPICAL	019968-001	Dec 17, 1990	4,619,921
Sun Pharm Inds Ltd	XIMINO	minocycline hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	201922-005	Jul 11, 2012	5,908,838
Sun Pharm Inds Ltd	XIMINO	minocycline hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	201922-003	Jul 11, 2012	5,908,838
Sun Pharm Inds Inc	EXELDERM	sulconazole nitrate	SOLUTION;TOPICAL	018738-001	Aug 30, 1985	4,055,652
Sun Pharm Inds Ltd	XIMINO	minocycline hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	201922-001	Jul 11, 2012	5,908,838
Sun Pharm Inds Inc	LAC-HYDRIN	ammonium lactate	LOTION;TOPICAL	019155-001	Apr 24, 1985	4,105,783

Paragraph IV (Patent) Challenges for SUN PHARM INDS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Capsules	30 mg and 40 mg		2012-12-31
	Capsules	20 mg		2013-06-19
	Capsules	25 mg		2016-05-16
	Delayed-release Tablets	20 mg		2015-06-03
	Capsules	20 mg		2013-01-07
	Capsules	35 mg		2015-11-25
	Injection	250 mcg/0.5 mL, 1 mL PFS		2012-03-30

International Patents for Sun Pharm Inds Drugs

Country	Patent Number	Estimated Expiration
Japan	6159567
World Intellectual Property Organization (WIPO)	2013171763
China	101208097
European Patent Office	1318791
New Zealand	564093
Iceland	6709
Israel	154307

Supplementary Protection Certificates for Sun Pharm Inds Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0503785	C300375	Netherlands		PRODUCT NAME: COMBINATIE VAN OLMESARTAN MEDOXOMIL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN AMLODIPINEBESILAAT; REGISTRATION NO/DATE: RVG100984, RVG100986-87, RVG100989-91, RVG100993-95 20080819
2203431	15C0013	France		PRODUCT NAME: DASABUVIR OU UN SEL DE CELUI-CI, NOTAMMENT LE SEL DE SODIUM; REGISTRATION NO/DATE: EU/1/14/983 20150119
2712622	122017000006	Germany		PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504
0496835	SPC/GB96/053	United Kingdom		PRODUCT NAME: DOXORUBICIN SULPHATE; REGISTERED: UK EU/1/96/011/001 19960621; UK EU/1/96/011/002 19960621
1685839	92292	Luxembourg		PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
1453521	C201630040	Spain		PRODUCT NAME: ETINILESTRADIOL Y MEZCLA DE LEVONORGESTREL Y ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: 80340; DATE OF AUTHORISATION: 20160122; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150211
0678503	C300499	Netherlands		PRODUCT NAME: COMBINATIE OMVATTEND ALISKIREN OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110114

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Sun Pharm Inds
• Sun Pharm Inds (in)
• Sun Pharm Inds Inc
• Sun Pharm Inds Ltd
• Sun Pharm Industries
• Sun Pharma Global